While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Delays in diagnosing and treating psoriatic arthritis—a common inflammatory disorder affecting around 200,000 people in the U ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

A deeper understanding of the inflammatory processes driving psoriasis and psoriatic arthritis is translating into new research approaches that could potentially benefit patients. Psoriasis is a ...